IUCRO-0498; Role of Osteocytes in Myeloma Bone Disease
The purpose of this study is to learn if substances that may cause bone destruction are increased in blood or bone marrow.
The investigators hope to determine serum FGF23 and heparanase, Dkk1 and plasma klotho levels in patients with newly diagnosed and relapsed myeloma compared to healthy controls with this exploratory study.
- IRB Number: 1407589587
- Research Study Identifier: TX4046
- Principal Investigator: Attaya Suvannasankha, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required